Comparative cell response to artificial extracellular matrix proteins containing the RGD and CS5 cell-binding domains.
Julie C Liu, Sarah C Heilshorn, David A Tirrell
Index: Biomacromolecules 5(2) , 497-504, (2004)
Full Text: HTML
Abstract
This study addresses endothelial cell adhesion and spreading on a family of artificial extracellular matrix (aECM) proteins designed for application in small-diameter vascular grafts. The aECM proteins contain domains derived from elastin and from fibronectin. aECM 1 contains the RGD sequence from the tenth type III domain of fibronectin; aECM 3 contains the fibronectin CS5 cell-binding domain. Negative control proteins aECM 2 and 4 are scrambled versions of aECM 1 and 3, respectively. Competitive peptide inhibition studies and comparisons of positive and negative control proteins confirm that adhesion of HUVECs to aECM proteins 1 and 3 is sequence specific. When subjected to a normal detachment force of 780 pN, 3-fold more HUVECs remained adherent to aECM 1 than to aECM 3. HUVECs also spread more rapidly on aECM 1 than on aECM 3. These results (i) indicate that cellular responses to aECM proteins can be modulated through choice of cell-binding domain and (ii) recommend the RGD sequence for applications that require rapid endothelial cell spreading and matrix adhesion.
Related Compounds
Related Articles:
1991-02-25
[J. Biol. Chem. 266(6) , 3579-85, (1991)]
1994-08-01
[Anticancer Drugs 5(4) , 424-8, (1994)]